Clinical trials
Observational Polyneuropathies trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 8 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Unknown status | 11 |
| Recruiting | 10 |
| Not yet recruiting | 5 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 3 |
| AstraZeneca | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Istituto Clinico Humanitas | 2 |
| Pfizer | 2 |
| Technical University of Munich | 2 |
| The Catholic University of Korea | 2 |
| University of Rostock | 2 |
| Aarhus University Hospital | 1 |
| Ain Shams University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polyneuropathies | 53 |
| Muscular Diseases | 7 |
| Peripheral Nervous System Diseases | 7 |
| Amyloid Neuropathies, Familial | 6 |
| Amyloidosis | 6 |
| Critical Illness | 6 |
| Amyloidosis, Familial | 4 |
| Diabetes Mellitus | 4 |
| Neuromuscular Diseases | 4 |
| Amyloid Neuropathies | 3 |
Trials
Showing 26 to 50 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.